Prior Authorization Legislation Takes Center Stage at Joint Hearing on Health Care Affordability
A joint hearing held on Jan. 22 by the U.S. House of Representatives Energy & Commerce Subcommittee on Health and the Ways and Means Committee hosted...
1 min read
brandon.rakes May 14, 2025
A revised local coverage determination, effective June 7, 2025, expands coverage for special histochemical stains and immunohistochemical (IHC) stains.
Cigna Government Services, the Medicare Administrative Contractor for Ohio and Kentucky, is expanding its coverage to include special histochemical and IHC stains across subspecialties such as breast, lung, and prostate pathology.
The services must be “medically necessary” for “a complete and accurate diagnosis” to be reported to the treating clinician, and the results of the test should be communicated to and used by the treating clinician for the beneficiary. The pathologist must also document why additional testing was performed.
The following scenarios are considered overutilization or incorrect billing of these services:
Billing and coding guidelines are available on the Centers for Medicare and Medicaid website.
Sources:
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=35986&ver=35

A joint hearing held on Jan. 22 by the U.S. House of Representatives Energy & Commerce Subcommittee on Health and the Ways and Means Committee hosted...
TELCOR has identified ongoing processing challenges with BCBS New Jersey that laboratories should be aware of. When claims require medical records,...
TELCOR has identified a recent process change with BCBSNebraska impacting payment timelines. As of November 1, 2025, BCBSNE adjustedits payment...